Andrle Edward has filed 7 insider transactions across 1 company since March 2023.
Most recent transaction: a grant/award of 41929 shares of NEUROONE MEDICAL TECHNOLOGIES Corp ($NMTC) on April 03, 2026.
| Transaction Date | Company | Ticker | Insider Name | Title | Transaction Type | Security | Shares | Price | Shares Owned Following | Total Shares Outstanding | % of Owned | % of Outstanding |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| April 3, 2026 | NEUROONE MEDICAL TECHNOLOGIES Corp | $NMTC | Andrle Edward | Director | A | Common Stock | 41929 | $0.00 | 133,932.0000 | 50,331,155 | 45.57% | 0.08% |
| April 3, 2026 | NEUROONE MEDICAL TECHNOLOGIES Corp | $NMTC | Andrle Edward | Director | A | Option to Purchase Common Stock | 26036 | $0.00 | 26,036.0000 | 50,331,155 | 9999.99% | 0.05% |
| June 23, 2025 | NEUROONE MEDICAL TECHNOLOGIES Corp | $NMTC | Andrle Edward | Director | A | Option to Purchase Common Stock | 50000 | $0.00 | 50,000.0000 | 31,111,786 | 9999.99% | 0.16% |
| Feb. 14, 2025 | NEUROONE MEDICAL TECHNOLOGIES Corp | $NMTC | Andrle Edward | Director | A | Option to Purchase Common Stock | 17025 | $0.00 | 17,025.0000 | 30,880,415 | 9999.99% | 0.06% |
| Feb. 14, 2025 | NEUROONE MEDICAL TECHNOLOGIES Corp | $NMTC | Andrle Edward | Director | A | Common Stock | 27778 | $0.00 | 92,003.0000 | 30,880,415 | 43.25% | 0.09% |
| March 16, 2023 | NEUROONE MEDICAL TECHNOLOGIES Corp | $NMTC | Andrle Edward | Director | A | Common Stock | 20576 | $0.00 | 64,225.0000 | 16,230,997 | 47.14% | 0.13% |
| March 16, 2023 | NEUROONE MEDICAL TECHNOLOGIES Corp | $NMTC | Andrle Edward | Director | A | Option to Purchase Common Stock | 18927 | $0.00 | 18,927.0000 | 16,230,997 | 9999.99% | 0.12% |